These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16981185)

  • 1. An efficient test for the analysis of dichotomized variables when the reliability is known.
    Borm GF; Munneke M; Lemmers O; van Zuijlen M
    Stat Med; 2007 Aug; 26(18):3498-510. PubMed ID: 16981185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials and the response rate illusion.
    Kirsch I; Moncrieff J
    Contemp Clin Trials; 2007 Jul; 28(4):348-51. PubMed ID: 17182286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the statistical power of different methods for the analysis of cluster randomization trials with binary outcomes.
    Austin PC
    Stat Med; 2007 Aug; 26(19):3550-65. PubMed ID: 17238238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calculation of sample size for stroke trials assessing functional outcome: comparison of binary and ordinal approaches.
    Optimising Analysis of Stroke Trials Collaboration
    Int J Stroke; 2008 May; 3(2):78-84. PubMed ID: 18705999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding clinical trial outcomes: design, analysis, and interpretation.
    Jacobe HT; Leitenberger JJ; Bergstresser PR
    Dermatol Ther; 2007; 20(2):77-85. PubMed ID: 17537135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robustness of an odds-ratio test in a stratified group sequential trial with a binary outcome measure.
    Srivastava DK; Rai SN; Pan J
    Biom J; 2007 Jun; 49(3):351-64. PubMed ID: 17623341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A permutation test for inference in logistic regression with small- and moderate-sized data sets.
    Potter DM
    Stat Med; 2005 Mar; 24(5):693-708. PubMed ID: 15515134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple method for calculating power based on a prior trial.
    Borm GF; Bloem BR; Munneke M; Teerenstra S
    J Clin Epidemiol; 2010 Sep; 63(9):992-7. PubMed ID: 20573484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Power and sample size when multiple endpoints are considered.
    Senn S; Bretz F
    Pharm Stat; 2007; 6(3):161-70. PubMed ID: 17674404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the Gould-Shih procedure for sample size re-estimation.
    Waksman JA
    Pharm Stat; 2007; 6(1):53-65. PubMed ID: 17133631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplicity-adjusted sample size requirements: a strategy to maintain statistical power with Bonferroni adjustments.
    Leon AC
    J Clin Psychiatry; 2004 Nov; 65(11):1511-4. PubMed ID: 15554764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimates, power and sample size calculations for two-sample ordinal outcomes under before-after study designs.
    Strickland PA; Lu SE
    Stat Med; 2003 Jun; 22(11):1807-18. PubMed ID: 12754716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the limitations of statistical analysis of treatment outcomes used in periodontal research.
    Galgut PN
    J Int Acad Periodontol; 2003 Oct; 5(4):92-7. PubMed ID: 14604057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis and importance of statistical power and sample size in empirical scientific research].
    Klimek KM
    Wiad Lek; 2008; 61(7-9):211-5. PubMed ID: 19172834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining sample size and power in clinical trials: the forgotten essential.
    Grimes DA; Schulz KF
    Semin Reprod Endocrinol; 1996 May; 14(2):125-31. PubMed ID: 8796935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the statistical power for multiple tests: a case study.
    Yeo A; Qu Y
    Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population enrichment designs: case study of a large multinational trial.
    Mehta CR; Gao P
    J Biopharm Stat; 2011 Jul; 21(4):831-45. PubMed ID: 21516572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of two-part models with competitors.
    Lachenbruch PA
    Stat Med; 2001 Apr; 20(8):1215-34. PubMed ID: 11304737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shifting our thinking about uncommon disease trials: the case of methotrexate in scleroderma.
    Johnson SR; Feldman BM; Pope JE; Tomlinson GA
    J Rheumatol; 2009 Feb; 36(2):323-9. PubMed ID: 19040308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How many repeated measurements are useful?
    Overall JE
    J Clin Psychol; 1996 May; 52(3):243-52. PubMed ID: 8835686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.